The link between obesity and diabetes

Type II diabetes is characterised by tissue resistance to insulin and is widespread in industrialised societies. A link between obesity and type II diabetes has long been suspected but details of the mechanism were unknown. Now, a newly discovered hormone described in 18 January Nature is proposed as the essential link between obesity and type II diabetes.Michell Lazar and colleagues from University of Pennsylvania School of Medicine found that adipocytes secrete a unique signalling protein, whi

By | January 18, 2001

Type II diabetes is characterised by tissue resistance to insulin and is widespread in industrialised societies. A link between obesity and type II diabetes has long been suspected but details of the mechanism were unknown. Now, a newly discovered hormone described in 18 January Nature is proposed as the essential link between obesity and type II diabetes.

Michell Lazar and colleagues from University of Pennsylvania School of Medicine found that adipocytes secrete a unique signalling protein, which they call 'resistin' (for resistance to insulin). They showed that in mice bred to have both diet-induced and hereditary diabetes the resistin levels are higher than in controls. A commonly used anti-diabetic drug (rosiglitazone) reduces the resistin levels and administering an anti-resistin antibody improves blood sugar and insulin action in mice with diet-induced obesity (Nature 2001, 409:307-312). The role of resistin in normal physiology is not known.

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Sequencing Reveals Genomic Diversity of the Human Brain
  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech